Read full plan here
Vision
By 2025, Canada will double the size of the health and biosciences sector and become a top-three global hub by: leveraging and advancing innovative technologies; attracting and retaining capital, skills and talent; and ensuring a vibrant ecosystem that will unleash the full potential of the sector and lead to improved health outcomes.
Business Wire National BioTech News
- New Clinical Data for Zanidatamab in HER2+ /HR+ Metastatic Breast Cancer Presented Today at 2022 SABCS
- IPA’s Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ and Accelerates in Silico Drug Discovery Developments
- VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults
- IMV Shareholders Approve Reverse Stock Split at 88%
- Healthcare BPO Market 2022-2028: Upcoming Increases in Healthcare Expenditure Across Key Markets to Fuel Growth - ResearchAndMarkets.com
- Synthetic Small Molecule API Market Report 2022: Increased Outsourcing of API Production Drives Growth - ResearchAndMarkets.com
- Aurion Biotech Appoints Jonathan Sparks, JD, PhD as Chief Legal Officer
- Metrion Biosciences and The KCNC1 Foundation Collaborate on Development of New Ion Channel Modulators for Ultra-Rare Genetic Disorder
- Cybin Presents CYB003 Preclinical Data at 2022 American College of Neuropsychopharmacology Annual Meeting
- CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal
RECENT TWEETS
Incredible news for Life Sciences in Atlantic Can! @EmerGenceBio has received $3.18M to get their next business plan off the ground which they expect will support 55 biosciences businesses annually! https://t.co/ePSLSfKDvd
